₹236.10
+0.23%NSE close, 16 Nov 2026
−28.43%
CHANDAN HEALTHCARE is a small cap company, listed on NSE SME under the symbol CHANDAN. At ₹236.10 a share, the market values the whole company at ₹577 crore. NSE SME is the exchange's platform for small and medium companies, which report their results every half year.
In FY26, it reported sales of ₹276 crore and a net profit of ₹27 crore, an operating margin of 19.0%.
Promoters hold 48.42% of the shares. Foreign institutions hold 0.00%, and domestic institutions, mutual funds among them, 5.06%.
Over the past year the share price has fallen 27.6%, and it is 34.1% below its 52-week high.
Listed on NSE SME, the platform for small and medium companies: its shares trade in large lots and often thinly, so the price can move sharply on a few trades, and companies file results every half year.
₹ crore. Consolidated figures.
| Line | 6M to Mar 2025 | 6M to Sep 2025 | Dec 2025 | 6M to Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|
| Sales | 120 | 136 | 65.0 | 141 | 80.9 | 58.0 |
The financial results for the period ended September 30, 2026.
Schedule of meet
Monitoring Agency Report for the quarter ended September 30, 2026.
Notice of Extraordinary General Meeting to be held on November 20, 2026
| Expenses | 98.2 | 108 | 53.2 | 116 | 61.3 | 37.7 |
|---|
| Operating profit | 21.5 | 28.3 | 11.8 | 24.3 | 19.6 | 20.3 |
|---|
| Operating margin | 18.0% | 20.8% | 18.2% | 17.3% | 24.2% | 34.9% |
|---|
| Other income | 1.1 | 1.7 | 0.8 | 2.6 | 1.4 | 1.8 |
|---|
| Interest | 2.4 | 2.8 | 1.3 | 3.1 | 4.8 | 4.8 |
|---|
| Depreciation | 3.5 | 4.9 | 2.4 | 4.9 | 4.5 | 4.6 |
|---|
| Profit before tax | 16.7 | 22.3 | 6.7 | 16.0 | 11.7 | 22.8 |
|---|
| Tax | 4.5 | 5.8 | 1.7 | 4.0 | 3.8 | 4.6 |
|---|
| Net profit | 11.5 | 15.6 | 4.5 | 11.5 | 7.5 | 18.2 |
|---|
| EPS (₹) | 5.60 | 6.38 | 1.86 | 4.69 | 3.07 | 7.44 |
|---|
₹ crore, financial years to March.
₹ crore, at each year's end and the latest half year.
₹ crore, by financial year, and the latest half year.
| Line | FY25 | FY26 | 6M to Sep 2026 |
|---|---|---|---|
| From operations | −29.1 | 16.2 | 29.5 |
| From investing | −35.8 | −39.9 | −50.6 |
| From financing | 67.1 | 21.1 | 49.8 |
| Spent on fixed assets | −38.7 | −42.6 | −59.4 |
| Free cash flow | −67.8 | −26.4 | −29.8 |
Margins, returns, debt, tax and cash.
| Line | FY25 | FY26 |
|---|---|---|
| Net margin | 9.6% | 9.8% |
| Operating margin | 18.0% | 19.0% |
| Return on equity | 18.1% | 15.9% |
| Return on capital employed | 21.5% | 19.7% |
| Return on assets | 10.5% | 9.4% |
| Debt to equity | 0.39 | 0.32 |
| Interest coverage | 8.00 | 7.50 |
| Debt to assets | 0.23 | 0.19 |
| Current ratio | 1.94 | 2.13 |
| Quick ratio | 1.39 | 1.69 |
| Cash ratio | 0.11 | 0.05 |
| Asset turnover | 1.09 | 0.95 |
| Fixed asset turnover | 3.20 | 2.85 |
| Inventory turnover | 3.40 | 4.00 |
| Receivables turnover | 4.90 | 3.20 |
| Gross margin | 53.2% | 51.6% |
| Cash from operations to profit | -131.0% | 60.0% |
| Effective tax rate | 26.7% | 25.4% |
A copy Srutinizers report of Annual General Meeting held on September 30, 2026. Further, the company has informed the Exchange regarding voting results.
Proceedings of Annual General Meeting held on September 30, 2026
Has informed regarding Disclosure of material issue